Contact Us    Downloads    Login 
   

              
 

Case Studies


NatImmune

  • Tired investors desiring a partnership of the lead protein replacement technology before further supporting the company
  • Sage engaged Enzon as well as three other parties
  • Closed a deal with $10 mil. in upfront fees and potential milestones of over $100 mil.
  • Double digit royalties dependent on sales
  • Investors re-invigorated.
  • Company subsequently made an acquisition for new pipeline

 Return to all case studies




Oxford UK – 19th April 2010 – Sense Proteomic Ltd. has announced the appointment of The Sage Group as its business development consultant to assist in expanding its global biomarker discovery partnerships. Sense is part of Ox...Read entire article



Cambridge UK and Clinton USA – December 2009 – The Sage Group is pleased to announce the appointment of two new seasoned Executive Directors – Dr. Tom Geimer in Australia and Dr. Laurence Shaw in Israel. Drs. Geimer and...Read entire article



Cambridge UK and Clinton USA – December, 2009 – The Sage Group, Inc. is pleased to announce the expansion of its global network with the opening of an Israeli office and the appointment of Dr. Laurence Shaw as Executive Direc...Read entire article

Contact Us

If you are interested in contacting us or obtaining the contact details for one of our offices, please use our contact page.

If you would like to make a more comprehensive business enquiry, you can send us further details of your company using our Business Enquiry Form.

© The Sage Group 2008 Site by YouSoft   Privacy Policy   Contact us